“Review Article: The Comparison of Effectiveness and Side Effects of Pembrolizumab in Combination with Chemotherapy versus Single Chemotherapy in the Treatment of Non-Small Cell Lung Cancer (NSCLC)” (2025) Journal of Pharmaceutical and Sciences, 8(2), pp. 1336–1354. doi:10.36490/journal-jps.com.v8i2.684.